Annual CFO
-$981.03 K
+$586.07 K+37.40%
December 31, 2023
Summary
- As of February 7, 2025, CHRO annual cash flow from operations is -$981.03 thousand, with the most recent change of +$586.07 thousand (+37.40%) on December 31, 2023.
- During the last 3 years, CHRO annual CFO has risen by +$2.64 million (+72.94%).
- CHRO annual CFO is now at all-time high.
Performance
CHRO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$177.91 K
+$2.77 M+93.97%
September 30, 2024
Summary
- As of February 7, 2025, CHRO quarterly cash flow from operations is -$177.91 thousand, with the most recent change of +$2.77 million (+93.97%) on September 30, 2024.
- Over the past year, CHRO quarterly CFO has increased by +$178.90 thousand (+50.14%).
- CHRO quarterly CFO is now -2.60% below its all-time high of -$173.40 thousand, reached on March 1, 2023.
Performance
CHRO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$5.48 M
+$79.29 K+1.43%
September 30, 2024
Summary
- As of February 7, 2025, CHRO TTM cash flow from operations is -$5.48 million, with the most recent change of +$79.29 thousand (+1.43%) on September 30, 2024.
- Over the past year, CHRO TTM CFO has dropped by -$4.50 million (-458.51%).
- CHRO TTM CFO is now -1459.64% below its all-time high of -$351.30 thousand, reached on March 1, 2022.
Performance
CHRO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CHRO Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +37.4% | +50.1% | -458.5% |
| 3 y3 years | +72.9% | +31.0% | -508.4% |
| 5 y5 years | +72.9% | +31.0% | -508.4% |
CHRO Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +38.4% | -2.6% | +94.0% | -1459.6% | +1.4% |
| 5 y | 5-year | at high | +72.9% | -2.6% | +94.0% | -1459.6% | +1.4% |
| alltime | all time | at high | +72.9% | -2.6% | +94.0% | -1459.6% | +1.4% |
Chromocell Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$177.91 K(-94.0%) | -$5.48 M(-1.4%) |
| Jun 2024 | - | -$2.95 M(+48.2%) | -$5.56 M(+98.5%) |
| Mar 2024 | - | -$1.99 M(+458.3%) | -$2.80 M(+185.4%) |
| Dec 2023 | -$981.03 K | -$356.81 K(+38.7%) | -$981.01 K(-24.0%) |
| Sep 2023 | - | -$257.20 K(+32.9%) | -$1.29 M(-0.0%) |
| Jun 2023 | - | -$193.60 K(+11.6%) | -$1.29 M(-7.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$173.40 K(-74.0%) | -$1.39 M(-11.4%) |
| Dec 2022 | -$1.57 M(-1.6%) | -$666.60 K(+158.6%) | -$1.57 M(+74.0%) |
| Sep 2022 | - | -$257.80 K(-11.5%) | -$900.50 K(+40.1%) |
| Jun 2022 | - | -$291.40 K(-17.1%) | -$642.70 K(+82.9%) |
| Mar 2022 | - | -$351.30 K | -$351.30 K |
| Dec 2021 | -$1.59 M(-56.1%) | - | - |
| Dec 2020 | -$3.63 M | - | - |
FAQ
- What is Chromocell Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Chromocell Therapeutics?
- What is Chromocell Therapeutics annual CFO year-on-year change?
- What is Chromocell Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Chromocell Therapeutics?
- What is Chromocell Therapeutics quarterly CFO year-on-year change?
- What is Chromocell Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Chromocell Therapeutics?
- What is Chromocell Therapeutics TTM CFO year-on-year change?
What is Chromocell Therapeutics annual cash flow from operations?
The current annual CFO of CHRO is -$981.03 K
What is the all time high annual CFO for Chromocell Therapeutics?
Chromocell Therapeutics all-time high annual cash flow from operations is -$981.03 K
What is Chromocell Therapeutics annual CFO year-on-year change?
Over the past year, CHRO annual cash flow from operations has changed by +$586.07 K (+37.40%)
What is Chromocell Therapeutics quarterly cash flow from operations?
The current quarterly CFO of CHRO is -$177.91 K
What is the all time high quarterly CFO for Chromocell Therapeutics?
Chromocell Therapeutics all-time high quarterly cash flow from operations is -$173.40 K
What is Chromocell Therapeutics quarterly CFO year-on-year change?
Over the past year, CHRO quarterly cash flow from operations has changed by +$178.90 K (+50.14%)
What is Chromocell Therapeutics TTM cash flow from operations?
The current TTM CFO of CHRO is -$5.48 M
What is the all time high TTM CFO for Chromocell Therapeutics?
Chromocell Therapeutics all-time high TTM cash flow from operations is -$351.30 K
What is Chromocell Therapeutics TTM CFO year-on-year change?
Over the past year, CHRO TTM cash flow from operations has changed by -$4.50 M (-458.51%)